SGLT2 Inhibition and Tubular Sodium Handling

J Am Soc Nephrol. 2024 Feb 1;35(2):131-133. doi: 10.1681/ASN.0000000000000280. Epub 2023 Dec 22.

Authors

Biff F Palmer¹, Deborah J Clegg²

Affiliations

¹ Internal Medicine, Department of Medicine, Division of Nephrology, University of Texas Southwestern Medical Center, Dallas, Texas.
² Internal Medicine, Vice President for Research, Texas Tech Health Sciences Center, El Paso, Texas.

PMID: 38129943
PMCID: PMC10843184 (available on 2025-02-01)
DOI: 10.1681/ASN.0000000000000280

No abstract available

MeSH terms

Diabetes Mellitus, Type 2*
Glucose / pharmacology
Humans
Sodium
Sodium-Glucose Transporter 2
Sodium-Glucose Transporter 2 Inhibitors* / pharmacology
Sodium-Glucose Transporter 2 Inhibitors* / therapeutic use

Substances

Sodium
Sodium-Glucose Transporter 2
Glucose
Sodium-Glucose Transporter 2 Inhibitors